首页> 外文期刊>The journal of knee surgery >Can Teicoplanin Be an Effective Choice for Antibiotic-Impregnated Cement Spacer in Two-Stage Revision Total Knee Arthroplasty?
【24h】

Can Teicoplanin Be an Effective Choice for Antibiotic-Impregnated Cement Spacer in Two-Stage Revision Total Knee Arthroplasty?

机译:Teicoplanin可以是两级修订中抗生素浸渍水泥间隔物的有效选择总膝关节置换术?

获取原文
获取原文并翻译 | 示例
           

摘要

The main purpose of this study was to evaluate the clinical results of two-stage revision total knee arthroplasty using a teicoplanin-impregnated cement spacer for infected primary total knee replacements. Twenty-five patients operated between 2005 and 2012 were included in this study. At the clinical status analysis, rate of infection eradication was assessed, physical examination was performed, Knee Society Score (KSS) was noted, isolated microorganisms were recorded, and the radiographic evaluation was performed. The mean KSS improved from 40 (range, 25-69) preoperatively to 77 (range, 32-96) at the latest follow-up (p < 0.05). Methicillin-resistant Staphylococcus epidermidis was isolated in 9 of 25 patients as the most frequently isolated pathogen, and the other isolated pathogens were methicillin-susceptible S. epidermidis, methicillin-resistant Staphylococcus aureus, and methicillin-susceptible S. aureus. Infection was successfully eradicated in 24 of 25 patients. Two-stage revision of the infected primary knee replacement is a time-consuming but a reliable procedure with high rates of success. Teicoplanin was found to be an effective choice for antibiotic-impregnated cement spacer applied for the eradication of the infection.
机译:本研究的主要目的是评估双阶段修订全膝关节成形术的临床结果,使用Teicoplanin浸渍的水泥间隔物用于感染的初级总膝关节置换。 2005年至2012年间运营的二十五名患者纳入本研究。在临床状态分析中,评估感染率,进行体格检查,注意到膝关节社会评分(KSS),记录孤立的微生物,进行射线照相评估。最新随访(P <0.05),平均KSS在术前从40(范围25-69)改善为77(32-96)(P <0.05)。耐药葡萄球菌的甲氧基硫脲葡萄球菌在25名患者中分离出最常见的病原体,另一种分离的病原体是甲氧西林 - 易感性的甲氧基菌丝,耐甲氧西林葡萄球菌和甲氧西林 - 易感金黄色葡萄球菌。在25例患者中成功地消除了感染。受感染的初级膝关节置换的两阶段修订是耗时,但具有高成功率的可靠程序。发现Teicoplanin是抗生素浸渍的水泥间隔物用于消除感染的有效选择。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号